Table B.2.
Test system | Protective agent | Results | Reference |
---|---|---|---|
Human hepatoma cells (HepG2) | Alpha‐tocopherol, alpha‐tocopherolphosphate, epigallocatechin gallate, quercetin, catechin and rosmarinic acid | No protection against cytotoxicity | Bösch‐Saadatmandi et al. (2006) |
Human proximal kidney tubule cells (HK‐2) | N‐Acetyl‐L‐cysteine | Reduction of reactive oxygen species and DNA strand breaks | Arbillaga et al. (2007) |
Pretreatment of pig kidney cell line (LLC‐PK1) | Epigallocatechin gallate and epicatechin gallate (antioxidant catechins) | Reduction of cell death, reactive oxygen and DNA fragmentation | Costa et al. (2007) |
Gut epithelial cell line (Caco‐2) | N‐acetylcysteine | Protected against loss of claudins from membranes associated with tight junctions | Lambert et al. (2007) |
Intestinal cells (Caco‐2\TC7) | De‐alcoholated Red wine |
Increased tight junction permeability Increased relocation of claudin‐4; Increased apoptosis |
Ranaldi et al. (2007) |
Bovine mammary epithelial cells; Porcine primary fibroblasts; Madin‐Darby canine kidney cells (MDCK) | Alpha‐tocopherol | Decreased apoptotic cell death | Fusi et al. (2008, 2010, 2018) |
Human hepatoma cells (HepG2) | Ebselen or vitamin E | No protection against cytotoxicity | El Golli Bennour et al. (2009) |
Human Caco‐2\TC7 cells | Zinc chelation | Increased apoptosis and permeability of tight junctions (reversed by zinc supplementation) | Ranaldi et al. (2009) |
Pig kidney cells (LLC‐PK1) | Leontopodic acid pretreatment | Reduced production of reactive oxygen species but did not inhibit cytotoxicity | Costa et al. (2010) |
Primary rat hepatocytes | Silibinin | Decrease in apoptotic cell death; decreased lipid peroxidation | Essid and Petzinger (2011), Essid et al. (2012) |
Human peripheral blood mononuclear cells | N‐acetylcysteine | Reduction of reactive oxygen, DNA damage, cell cycle G1 arrest and downregulation of CDK4 and cyclinD1 | Liu et al. (2012) |
Monkey kidney cells (Vero cell line) | Quercetin |
Reduced apoptosis and oxidative stress Reduced DNA damage |
Ramyaa and Padma (2013) |
Madin‐Darby canine kidney cells (MDCK) | Diosmetin flavonoid | Prevents ATP depletion | Poór et al. (2014) |
Human embryonic kidney (HEK293) cells | N‐acetylcysteine | Reduced reactive oxygen production; reduced loss of mitochondrial membrane potential; reduced loss of superoxide dismutase activity; reduced DNA strand breaks and cell cycle arrest | Yang et al. (2014) |
Intestinal cells (Caco‐2) | Resveratrol | Increased cytotoxicity without an increase in reactive oxygen species | Cano‐Sancho et al. (2015) |
Vero cells, and lymphocytes in vitro and mice in vivo | Polyphenols (caffeic acid, luteolin and chlorogenic acid | Reduction of cytotoxicity (chlorogenic acid and caffeic acid); inhibition of DNA strand breaks (caffeic acid and chlorogenic acid) and inhibition of micronucleation (chlorogenic acid) | Cariddi et al. (2015) |
Human peripheral blood lymphocytes | Sodium copper chlorophyllin | Reduced cytotoxicity and reduced DNA damage | Domijan et al. (2015) |
Porcine kidney cells (PK15) | Selenomethionine; overexpressed selenoprotein S | Reduced cytotoxicity (by selenomethionine, evidently via induction of glutathione peroxidase); Inhibition of promotion of viral replication (selenoprotein S) | Gan et al. (2015, 2016) |
Human hepatoma cells (HepG2) | Vitamin E | Reduced cytotoxicity and reactive oxygen production | Gayathri et al. (2015) |
Human embryonic kidney cells (HEK293) | Resveratol | Reduced DNA strand breaks | Raghubeer et al. (2015) |
Neuro‐2a cells | N‐acetylcysteine pretreatment | Protected against apoptotic cell death | Bhat et al. (2016) |
Monkey kidney cells (Vero cell line) | Superoxide dismutase mimic (MnTnHex‐2‐PyP) |
Decreased reactive oxygen concentration Decreased cytotoxicity |
Costa et al. (2016) |
Porcine kidney cells (PK‐15) |
N‐acetylcysteine Selenomethionine |
Reduced autophagy | Qian et al. (2017, 2018) |
ATP: adenosin triphosphate; CDK4: Cyclin‐dependent kinase 4; DNA: deoxyribonucleic acid; OTA; ochratoxin A; G1: Gap 1 phase.